Current Treatments in Mantle Cell Lymphoma
Oncology (Williston Park). 2023 Aug 8;37(8):326-333. doi: 10.46883/2023.25921002.ABSTRACTMantle cell lymphoma (MCL) is characterized by heterogeneous biology and varied clinical presentations. Historically, it has been associated with a poor prognosis when compared with other non-Hodgkin lymphomas. With a better understanding of the disease biology, molecular pathogenesis, and new treatments, the outcomes have been gradually improving. Identification of high-risk mutations has resulted in better prognostication and paved the way for risk-adapted treatment approaches. Although chemoimmunotherapy remains the mainstay frontli...
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: None Avyakta Kallam Md Julie M Vose Source Type: research
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass
CONCLUSIONS: This case demonstrates a very unusual HCC presentation, the importance of a thorough workup of bone metastasis, and the limited value of AFP for HCC screening, even in disseminated disease.PMID:37616520 | DOI:10.46883/2023.25921003 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: Rohit Gupta Joshua Hirsch Maya Guhan Jeffrey Triska Ruben Hernaez Addison Taylor Source Type: research
Current Treatments in Mantle Cell Lymphoma
Oncology (Williston Park). 2023 Aug 8;37(8):326-333. doi: 10.46883/2023.25921002.ABSTRACTMantle cell lymphoma (MCL) is characterized by heterogeneous biology and varied clinical presentations. Historically, it has been associated with a poor prognosis when compared with other non-Hodgkin lymphomas. With a better understanding of the disease biology, molecular pathogenesis, and new treatments, the outcomes have been gradually improving. Identification of high-risk mutations has resulted in better prognostication and paved the way for risk-adapted treatment approaches. Although chemoimmunotherapy remains the mainstay frontli...
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: None Avyakta Kallam Md Julie M Vose Source Type: research
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass
CONCLUSIONS: This case demonstrates a very unusual HCC presentation, the importance of a thorough workup of bone metastasis, and the limited value of AFP for HCC screening, even in disseminated disease.PMID:37616520 | DOI:10.46883/2023.25921003 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: Rohit Gupta Joshua Hirsch Maya Guhan Jeffrey Triska Ruben Hernaez Addison Taylor Source Type: research
Current Treatments in Mantle Cell Lymphoma
Oncology (Williston Park). 2023 Aug 8;37(8):326-333. doi: 10.46883/2023.25921002.ABSTRACTMantle cell lymphoma (MCL) is characterized by heterogeneous biology and varied clinical presentations. Historically, it has been associated with a poor prognosis when compared with other non-Hodgkin lymphomas. With a better understanding of the disease biology, molecular pathogenesis, and new treatments, the outcomes have been gradually improving. Identification of high-risk mutations has resulted in better prognostication and paved the way for risk-adapted treatment approaches. Although chemoimmunotherapy remains the mainstay frontli...
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: None Avyakta Kallam Md Julie M Vose Source Type: research
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass
CONCLUSIONS: This case demonstrates a very unusual HCC presentation, the importance of a thorough workup of bone metastasis, and the limited value of AFP for HCC screening, even in disseminated disease.PMID:37616520 | DOI:10.46883/2023.25921003 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: Rohit Gupta Joshua Hirsch Maya Guhan Jeffrey Triska Ruben Hernaez Addison Taylor Source Type: research
Current Treatments in Mantle Cell Lymphoma
Oncology (Williston Park). 2023 Aug 8;37(8):326-333. doi: 10.46883/2023.25921002.ABSTRACTMantle cell lymphoma (MCL) is characterized by heterogeneous biology and varied clinical presentations. Historically, it has been associated with a poor prognosis when compared with other non-Hodgkin lymphomas. With a better understanding of the disease biology, molecular pathogenesis, and new treatments, the outcomes have been gradually improving. Identification of high-risk mutations has resulted in better prognostication and paved the way for risk-adapted treatment approaches. Although chemoimmunotherapy remains the mainstay frontli...
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: None Avyakta Kallam Md Julie M Vose Source Type: research
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass
CONCLUSIONS: This case demonstrates a very unusual HCC presentation, the importance of a thorough workup of bone metastasis, and the limited value of AFP for HCC screening, even in disseminated disease.PMID:37616520 | DOI:10.46883/2023.25921003 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: Rohit Gupta Joshua Hirsch Maya Guhan Jeffrey Triska Ruben Hernaez Addison Taylor Source Type: research
Current Treatments in Mantle Cell Lymphoma
Oncology (Williston Park). 2023 Aug 8;37(8):326-333. doi: 10.46883/2023.25921002.ABSTRACTMantle cell lymphoma (MCL) is characterized by heterogeneous biology and varied clinical presentations. Historically, it has been associated with a poor prognosis when compared with other non-Hodgkin lymphomas. With a better understanding of the disease biology, molecular pathogenesis, and new treatments, the outcomes have been gradually improving. Identification of high-risk mutations has resulted in better prognostication and paved the way for risk-adapted treatment approaches. Although chemoimmunotherapy remains the mainstay frontli...
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: None Avyakta Kallam Md Julie M Vose Source Type: research
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass
CONCLUSIONS: This case demonstrates a very unusual HCC presentation, the importance of a thorough workup of bone metastasis, and the limited value of AFP for HCC screening, even in disseminated disease.PMID:37616520 | DOI:10.46883/2023.25921003 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: Rohit Gupta Joshua Hirsch Maya Guhan Jeffrey Triska Ruben Hernaez Addison Taylor Source Type: research
Current Treatments in Mantle Cell Lymphoma
Oncology (Williston Park). 2023 Aug 8;37(8):326-333. doi: 10.46883/2023.25921002.ABSTRACTMantle cell lymphoma (MCL) is characterized by heterogeneous biology and varied clinical presentations. Historically, it has been associated with a poor prognosis when compared with other non-Hodgkin lymphomas. With a better understanding of the disease biology, molecular pathogenesis, and new treatments, the outcomes have been gradually improving. Identification of high-risk mutations has resulted in better prognostication and paved the way for risk-adapted treatment approaches. Although chemoimmunotherapy remains the mainstay frontli...
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: None Avyakta Kallam Md Julie M Vose Source Type: research
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass
CONCLUSIONS: This case demonstrates a very unusual HCC presentation, the importance of a thorough workup of bone metastasis, and the limited value of AFP for HCC screening, even in disseminated disease.PMID:37616520 | DOI:10.46883/2023.25921003 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: Rohit Gupta Joshua Hirsch Maya Guhan Jeffrey Triska Ruben Hernaez Addison Taylor Source Type: research
Current Treatments in Mantle Cell Lymphoma
Oncology (Williston Park). 2023 Aug 8;37(8):326-333. doi: 10.46883/2023.25921002.ABSTRACTMantle cell lymphoma (MCL) is characterized by heterogeneous biology and varied clinical presentations. Historically, it has been associated with a poor prognosis when compared with other non-Hodgkin lymphomas. With a better understanding of the disease biology, molecular pathogenesis, and new treatments, the outcomes have been gradually improving. Identification of high-risk mutations has resulted in better prognostication and paved the way for risk-adapted treatment approaches. Although chemoimmunotherapy remains the mainstay frontli...
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: None Avyakta Kallam Md Julie M Vose Source Type: research
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass
CONCLUSIONS: This case demonstrates a very unusual HCC presentation, the importance of a thorough workup of bone metastasis, and the limited value of AFP for HCC screening, even in disseminated disease.PMID:37616520 | DOI:10.46883/2023.25921003 (Source: Oncology (Williston Park, N.Y.))
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: Rohit Gupta Joshua Hirsch Maya Guhan Jeffrey Triska Ruben Hernaez Addison Taylor Source Type: research
Current Treatments in Mantle Cell Lymphoma
Oncology (Williston Park). 2023 Aug 8;37(8):326-333. doi: 10.46883/2023.25921002.ABSTRACTMantle cell lymphoma (MCL) is characterized by heterogeneous biology and varied clinical presentations. Historically, it has been associated with a poor prognosis when compared with other non-Hodgkin lymphomas. With a better understanding of the disease biology, molecular pathogenesis, and new treatments, the outcomes have been gradually improving. Identification of high-risk mutations has resulted in better prognostication and paved the way for risk-adapted treatment approaches. Although chemoimmunotherapy remains the mainstay frontli...
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: None Avyakta Kallam Md Julie M Vose Source Type: research
